Balance Sheet
Cash Flow Statement
AmortizationAmortizationAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet Income
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Net Cash Flow (2016 - 2025)

Avricore Health has reported Net Cash Flow over the past 12 years, most recently at -$218126.2 for Q4 2025.

  • Quarterly Net Cash Flow fell 186.6% to -$218126.2 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$656225.8 through Dec 2025, down 205.13% year-over-year, with the annual reading at -$647223.3 for FY2025, 203.53% down from the prior year.
  • Net Cash Flow was -$218126.2 for Q4 2025 at Avricore Health, up from -$235193.6 in the prior quarter.
  • Over five years, Net Cash Flow peaked at $1.8 million in Q1 2021 and troughed at -$441164.3 in Q3 2022.
  • The 5-year median for Net Cash Flow is -$81345.1 (2023), against an average of -$703.16.
  • Year-over-year, Net Cash Flow skyrocketed 467.03% in 2021 and then tumbled 1335.66% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at -$167766.8 in 2021, then decreased by 9.17% to -$183145.8 in 2022, then skyrocketed by 54.7% to -$82973.1 in 2023, then skyrocketed by 403.58% to $251888.7 in 2024, then crashed by 186.6% to -$218126.2 in 2025.
  • Per Business Quant, the three most recent readings for AVCRF's Net Cash Flow are -$218126.2 (Q4 2025), -$235193.6 (Q3 2025), and -$298431.0 (Q2 2025).